MSB 5.24% $1.11 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-20

  1. 7 Posts.
    lightbulb Created with Sketch. 1
    Thank you Silvu for delivering on your promise that shareholders would receive a significant update in the first quarter. This news changes everything. Happy Easter everyone.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.